In the group of non-osteoporotic vertebral fractures, the fracture risk in women carrying the CT and TT genotype of MTHFR (rs1801133) was 3.684 times higher than that in women carrying the CC genotype with a 95% CI of 1.604 - 8.461 (p< 0.05).